Trial Profile
Serial 123-I MIBG imaging for assessing the progression of myocardial denervation in patients with familial amyloid polyneuropathy
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Iobenguane (Primary)
- Indications Amyloid polyneuropathy
- Focus Diagnostic use
- 21 Oct 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.